PURPOSE. Age-related macular degeneration (AMD) is a common cause of irreversible vision loss in the elderly. The hypothesis was that in vitro stimulation of RPE cells with A␤ 1-40 , a constituent of drusen, promotes changes in gene expression and cellular pathways associated with the pathogenesis of AMD, including oxidative stress, inflammation, and angiogenesis. METHODS. Confluent human RPE cells were stimulated with A␤ 1-40 , or the reverse peptide A␤ 40-1 , and genome wide changes in gene expression were studied with gene microarrays. Selected genes were verified by qRT-PCR and ELISA. Pathway analysis with gene set enrichment analysis (GSEA) and ingenuity revealed top functional pathways in RPE after A␤ 1-40 stimulation. RESULTS. RPE cells stimulated with A␤ 1-40 (0.3 M) for 24 hours resulted in 63 upregulated and 22 downregulated previously known genes. The upregulated genes were predominantly in inflammatory and immune response categories, but other categories were also represented, including apoptosis, cell signaling, cell proliferation, and signal transduction. Categories of downregulated genes included immune response, transporters, metabolic functions and transcription factors. ELISA confirmed that secreted levels of IL-8 were two times higher than control levels. GSEA and ingenuity analysis confirmed that the top affected pathways in RPE cells after A␤ 1-40 stimulation were inflammation and immune response related. Surprisingly, few angiogenic pathways were activated at the doses and exposure times studied. CONCLUSIONS. A␤ 1-40 promotes RPE gene expression changes in pathways associated with immune response, inflammation, and cytokine and interferon signaling pathways. Results may relate to in vivo mechanisms associated with the pathogenesis of AMD. (Invest Ophthalmol Vis Sci. 2010;51:1151-1163) DOI: 10.1167/iovs.09-3622 A ge-related macular degeneration (AMD) is the most common cause of irreversible vision loss in the elderly. The disease is characterized by extracellular deposits known as drusen, which are found between the basal lamina of the retinal pigment epithelium (RPE) and the inner layer of Bruch's membrane (BM). Although, the presence of drusen correlates with the development of AMD, the specific mechanisms underlying the biogenesis of drusen and its relationship to the disease remain elusive.
A ge-related macular degeneration (AMD) is the most common cause of irreversible vision loss in the elderly. The disease is characterized by extracellular deposits known as drusen, which are found between the basal lamina of the retinal pigment epithelium (RPE) and the inner layer of Bruch's membrane (BM). Although, the presence of drusen correlates with the development of AMD, the specific mechanisms underlying the biogenesis of drusen and its relationship to the disease remain elusive. [1] [2] [3] Extensive biochemical analysis of drusen revealed the presence of several proteins linked to inflammation. Such proteins include immunoglobulins, acutephase molecules (vitronectin, amyloid P, and fibrinogen), complement factors (C5 and C5b-9), and complement regulatory molecules (clusterin and complement receptor 1). 4 -8 These findings implicate an inflammatory process associated with drusen, but what activates or triggers the inflammation remains unknown. 4,9 -12 Several lines of evidence suggest that amyloid-␤ 1-40 (A␤ ), a known constituent of drusen, is a potential candidate trigger peptide. 3, [13] [14] [15] Genetically modified mice with increased A␤ deposition display many traits consistent with human AMD, such as the accumulation of sub-RPE deposits, microglial activation, and degeneration of the retinal neurons and RPE. 16, 17 In the retina, cell types including neurons, RPE, and glia may provide a local source of A␤ species; they have been shown to have the cellular machinery for the synthesis of amyloid precursor protein (APP) and cleavage enzymes. 10 Sequential APP processing by ␤-and ␥-secretase produces the major A␤ species, A␤ . Recent in vitro studies in which RPE cells are stimulated with A␤ 1-40 demonstrated several results that are consistent with a proinflammatory response. Wang et al. 18 reported that A␤ stimulation caused abnormal activity of complement factor I (CFI), an inhibitory regulator of the complement cascade. In another study, stimulation of RPE cells with A␤ 1-40 modulated the expression of vascular endothelial growth factor (VEGF), which is known to promote angiogenesis, a late-stage feature of AMD. 17 These results prompted us to further elucidate the effects of A␤ stimulation on RPE cells in vitro by differential microarrays and corresponding functional pathway analysis. We hypothesize that A␤ stimulation of RPE cells in vitro promotes gene expression changes associated with cellular pathways implicated in the pathogenesis of AMD, including oxidative stress, inflammation, angiogenesis, and apoptosis.
A␤ peptide and the control reverse peptide A␤ 40-1 were purchased from American Peptide (Sunnyvale, CA) as a salt-free, lyophilized powder. The protocol used to synthesize A␤ oligomers was obtained from Invitrogen Canada (Burlington, ON, Canada). Briefly, lyophilized A␤ ( or the reverse peptide A␤ ) was dissolved in 200 L hexafluoroisopropanol (HFIP) and sonicated for 30 seconds. The HFIP solution was then transferred by a 22-gauge syringe to a new 1.4-mL tube (Eppendorf, Fremont, CA) containing 700 L of distilled water. A Teflon-coated micromagnetic stirring bar was added, and the tube was closed with a perforated cap to allow HFIP to vent after evaporation. The tube was placed in a holder inside a fume hood on top of a stirring plate, and stirred with a Teflon-coated micro stir bar at 300 rpm for 24 to 48 hours. Aliquots of the supernatant were analyzed for confirmation of A␤ oligomers using atomic force microscopy (AFM) and dot blot assay.
Atomic Force Microscopy
AFM was performed as previously described. 21, 22 Briefly, A␤ samples were prepared for AFM examination by placing 10 L of solution onto freshly cleaved mica (Ted Pella, Inc., Redding, CA). The sample was allowed to adhere to the mica surface for 10 minutes at room temperature and was subsequently washed with double-distilled water to eliminate contamination due to buffer and salts and to help reduce background contrast. AFM images were captured with a microscope (BioScope with the Nanoscope IIIa Controller and a G-type scanner; Digital Instruments, Santa Barbara, CA). The contact mode was used for all images with DNP silicon nitride cantilevers (Digital Instruments). A minimum of four random regions of the mica surface was examined to ensure that similar structures existed throughout the sample.
Dot Blot Assay
A dot blot assay was performed to determine the oligomeric form A␤ . Approximately 3 L of A␤ solution was spotted onto a nitrocellulose membrane and allowed to dry. The membrane was then blocked with 10% nonfat dry milk in Tris-buffered saline (TBS) containing 0.01% Tween 20 (TBST) solution overnight at 4°C, and washed three times in full-strength TBST for 5 minutes before being incubated for 1 hour at room temperature with the A11 anti-oligomer antibody using the manufacturer's protocol (Invitrogen Corp., Carlsbad, CA). The membrane was then washed three times in TBST for 5 minutes and incubated for 1 hour at room temperature with a standard horseradish peroxidase-conjugated secondary antibody made in goat against rabbit IgG diluted at 1:2000 (Promega, Madison, WI). The blots were finally washed three times in TBST for 5 minutes and developed for 20 minutes in a solution of tetramethylbenzidine (TMB; Promega).
Cell Culture of Human RPE Cells
Human fetal RPE cells were used in all the experiments. Human RPE cells were isolated from fetal donor eye tissues, as described elsewhere. 23, 24 Methods for securing human tissue were humane and included proper written informed consent, which complied with the Declaration of Helsinki. Human fetal donor eyes had no known disease and were used under the guidelines and regulation of the IRB at the University of British Columbia, Vancouver, Canada. The eyes were cut circumferentially, the vitreous removed, and the neuroretina gently detached from the RPE cell layer. The choroid/RPE layer was placed in 2% Dispase (Invitrogen) in Hanks' balanced salt solution (HBSS; Invitrogen) for 25 minutes at 37°C. The RPE layer was then removed in fragments and passed through 70-and 40-m nylon mesh filters (Falcon Plastics, Oxnard, CA). Only the fragments that were left behind were retained. After centrifugation at 1500 rpm for 5 minutes, the fragments were gently dissociated and seeded on to laminin-coated six-well plates (Falcon Plastics). RPE cells were cultured in Dulbecco's modified Eagle's medium (DMEM; Invitrogen-Gibco, Grand Island, NY) containing 10% fetal bovine serum (FBS; Invitrogen-Gibco), 100 g/mL penicillin (Sigma-Aldrich, St. Louis, MO), 100 g/mL streptomycin (Sigma-Aldrich), and 2 mM L-glutamine (Invitrogen) at 37°C in a humidified atmosphere of 95% air and 5% CO 2 . At confluence, the cells were detached with 0.05% trypsin/0.02% EDTA (Invitrogen), collected by centrifugation, and expanded. In the following experiments, passage 5 cells were used, and RPE cells from the same donor were used in an individual experiment.
Cell Viability Assay
RPE cells (20 ϫ 10 3 cells/well) were seeded in 200 L medium on a 96-well culture plate and incubated with DMEM containing 10% FBS, for 24 hours. The medium was then discarded, and the cells were washed three times with phosphate-buffered saline (PBS). The MTT reduction assay was used as an index of cell viability. Briefly, the oligomeric form of A␤ (0.01, 0.3, 1.0, 5.0, and 10.0 M) and the control, reverse peptide, A␤ 40-1 (0.3 M) were used to stimulate RPE cells for various lengths of time (3, 6, 12, or 24 hours). After stimulation, the media were aspirated and the RPE cells were subsequently incubated in serum-free medium containing 0.4 mg/mL MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] for 4 hours. Mitochondrial and cytosolic dehydrogenases of living cells reduced the yellow tetrazolium salt (MTT) to a purple formosan dye that was then detected by spectrophotometry. After 4 hours, the MTT solution was aspirated, and 150 L of dimethylsulfoxide (DMSO) was added for a period of 20 minutes. Optical densities of the supernatant were read at 550 nm with a microplate spectrophotometer (Bio-Tek Instruments, Inc., Winooski, VT). Absorbances were normalized to those of the untreated control cultures, which were also incubated in serum-free medium, which represented 100% viability. Two independent experiments in quadruplicate were performed in this study. The mean Ϯ SD of the data was analyzed.
A␤ Stimulation
RPE cells (0.3 ϫ 10 6 /well) were seeded in 2 mL of culture medium in a six-well plate for 4 days. Before stimulation, the cells were washed three times with PBS. The RPE cells were then treated with A␤ (the oligomeric form) or A␤ 40-1 (the reverse peptide) at a concentration of 0.3 M for 3, 6, 12, or 24 hours in 1 mL of serum-free DMEM. Untreated RPE cells containing only serum-free DMEM were used as the negative control. As the chemical constituents of serum often vary, serum-free DMEM was used in all stimulation studies to ensure a controlled experimental design.
Microarray and Data Analysis
The total cellular RNA was isolated from cultured human RPE cells according to manufacturer's recommendations (TRIzol; Invitrogen). RNA samples were then subsequently treated with DNase treatment and removal (TURBO DNA-free; Ambion, Streetsville, ON, Canada). Quantification of RNA was performed with spectrophotometry (ND-1000; NanoDrop Products, Thermo Fisher Scientific, Wilmington, DE). Total RNA integrity was confirmed with a bioanalyzer (model 2100; Agilent Technologies, Palo Alto, CA) according to the manufacturer's protocol.
The labeling and hybridization of the cRNA was performed at the Prostate Cancer Microarray Centre, University of British Columbia. One microgram of total RNA from all samples and from human universal reference RNA (Stratagene, La Jolla, CA) was amplified and labeled with fluorescent dyes (Cy3 and Cy5; Low RNA Input Linear Amplification Labeling Kit; Agilent Technologies) according to the manufacturer's protocol. The amount and specific activity of the resulting fluorescently labeled cDNA was assessed with the spectrophotometer. Equal amounts of Cy3-sample and Cy5-labeled universal human reference cDNA were cohybridized (Whole Human Genome Oligo Microarray; Agilent Technologies), comprising over 41,000 human genes and transcripts, for 18 hours before washing and scanning. Data were extracted from the resulting images (Feature Extraction Software; Agilent Technologies).
Red (Cy5 labeled cRNA) and green (Cy3 labeled cRNA) processed signals were entered into the computer software (GeneSpring 7.3.1; Agilent Technologies) and normalized via manufacturer's protocols for two-color experiments as follows: per spot, divide by control channel; per chip, normalize to the 50th percentile; per gene, normalized to median. The results represent the mean values from three independent experiments. A list of differentially expressed genes was generated by applying a t-test with P Ͻ 0.05 between the A␤ 1-40 -treated group and the untreated group and by applying a change filter with a cutoff of Ϯ1.5-fold. Linearization of the data was undertaken by log 2 transformation.
Real-Time Quantitative (q)RT-PCR
Reverse transcription reactions were performed for each RNA sample (1 g) using reverse transcription reagents (Superscript III; Invitrogen Canada). Real-time PCR was performed with a sequence-detection system (Prism 7300; Applied Biosystems [ABI], Foster City, CA). SYBR green PCR master mix (ABI) was used on cDNA samples in 96-well optical plates and analyzed by using qRT-PCR methods, as described elsewhere. 25 Oligonucleotide primers for all genes of interest and for the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were designed for real-time PCR on computer (Primer Express 2.0 software; ABI). All primers were purchased from Proligo LL (Boulder, CO). Relative quantification of gene expression was performed using the x-fold change method, as published 26 and as recommended by the manufacturer of the sequence detection system (ABI). The relative gene expression was represented by the difference between the normalized values of the experimental samples to that of corresponding sham controls (⌬⌬Ct). 2
Ϫ⌬⌬Ct for each product was used to calculate changes. A Pearson's correlation coefficient was used to calculate the correlation between microarray and qRT-PCR log 2 -fold changes.
ELISA
Levels of IL-1␤, Il-8, and tumor necrosis factor (TNF)-related apoptosisinducing ligand TNFSF10 (TRAIL) in the supernatant samples were measured using proteome arrays (SearchLight; Thermo Fisher Scientific, Woburn, MA). Samples were incubated for 1 hour on the array plates that were prespotted with capture antibodies specific for each protein biomarker. The plates were emptied and washed three times before the addition of a cocktail of biotinylated detection antibodies to each well and then were incubated for 30 minutes. The plates were then washed three times and incubated again for 30 minutes with streptavidin-horseradish peroxidase. All incubations were at a room temperature with agitation at 200 rpm. The plates were again washed before the addition of chemiluminescent substrate (SuperSignal Femto; Thermo Fisher Scientific) and were immediately imaged (SearchLight; Thermo Fisher Scientific) and the data analyzed (Array Analyst software; Ambion).
Gene Set Enrichment Analysis (GSEA)
To test for sets of related genes that might be systematically altered in A␤ -treated RPE cells, we performed studies of gene sets in functional pathways by analyzing our microarray dataset using GSEA. 27 A total of 1892 curated gene sets containing genes whose products are involved in specific metabolic and signaling pathways were obtained from pathway databases or from peer-reviewed published material. The gene sets were screened against the GSEA-ranked microarray data sets to calculate enrichment score (ES) for each gene set. An enrichment score reflects the degree to which a gene set is overrepresented at the extreme top or bottom of the ranked microarray data set list of genes. The curated gene sets were screened against the microarray data set, and enrichment plots were generated for each gene set. An enrichment plot displays a running enrichment score as a function of the rank-ordered probes in the microarray data set. To adjust for multiple hypothesis testing, the ES for each gene was normalized to account for the size of the set, yielding a normalized enrichment score (NES). The proportion of false positives was controlled for by calculating the false discovery rate (FDR) corresponding to each NES.
27,28

Pathway Analysis
Differentially expressed genes that met our criteria of selection were also analyzed for global functions, network, and canonical pathways (Ingenuity Pathway Analysis; Ingenuity Systems, Redwood City, CA). A spreadsheet (Excel; Microsoft, Redmond, WA) of our data containing a gene list with gene identifiers and corresponding changes was entered into the system, and patterns of differential gene expression were compared with those in the knowledge base (Pathways Knowledge Base; Ingenuity Systems).
RESULTS
Characterization of A␤ 1-40 Oligomers
After incubation for 48 hours, A␤ 1-40 oligomers were examined with the use of AFM and immunodot blot assay. AFM analysis showed that the oligomeric preparations were composed of small globular structures with a distinct lack of fibrils (Fig. 1A) . These results were consistent with those in previous studies. 29 -31 Dot blot examination with the anti-oligomeric specific antibody (A11) further confirmed the presence of oligomeric structures as it reacted positively with our A␤ 1-40 samples (Fig.  1B) . Furthermore, the A11 antibody did not react against a fibrillar standard sample of A␤ , confirming the specificity of the antibody to the oligomeric form.
RPE Cell Viability after Stimulation with A␤ 1-40 Oligomers
We used an MTT reduction assay to examine the effects of A␤ and the reverse peptide A␤ 40-1 on viability of confluent RPE. Figure 2A shows the dose-dependent effects of A␤ stimulation (0.001-0.3 M) at 3 hours. Note that the reverse peptide A␤ 40-1 had a minor effect on the viability of RPE (97% Ϯ 0.05% SD), compared with the DMEM control (100%). We also tested the effects of several doses of A␤ 1-40 (0.01-10.0 M) on RPE cell viability at the 24-hour exposure time. At 0.01 M A␤ 1-40 oligomers, the lowest dose, mean (SD) cell viability was measured to be 81% (0.08%) and decreased to 25% (0.06%) at 10.0 M (Fig. 2B) . We also examined the effects of 0.3 M A␤ 1-40 on the viability of RPE at 3, 6, 12, and 24 hours. Note that cell survival gradually dropped from 83% (0.03%) at 3 hours to 57% (0.07%) relative to the corresponding control cultures by 24 hours (Fig. 2C) .
Gene Expression Analysis of RPE Cells after A␤ 1-40 Stimulation
Analysis of the gene expression response of RPE cells after 0.3 M A␤ 1-40 treatment was undertaken by using wholegenome oligo arrays (Agilent). At 24 hours, we observed 63 upregulated and 20 downregulated previously known genes (Tables 1, 2 ). The upregulated genes were found predominantly in the immune response category, but several other categories were also represented, including apoptosis, transcription factors, transporters, cell proliferation, cell signaling, and signal transduction. The three upregulated genes that exhibited the greatest changes were IL-1␤ (4.8 Ϯ 0.49-fold), RSAD2 (2.58Ϯ 0.57-fold), and IL-8 (2.38 Ϯ 0.42-fold). Relatively few genes were downregulated in response to A␤ 1-40 stimulation. Categories of downregulated genes also included immune response, transporters, cell metabolism, and transcription factors.
Confirmation of Differentially Expressed Genes after A␤ 1-40 Stimulation
Real-time qRT-PCR was performed to validate 18 genes of interest that were shown to be differentially regulated by the microarray (black bars, Fig. 3 ). The gene-specific primer sequences used for qRT-PCR are shown in Table 3 . The amplified product for a housekeeping gene, GAPDH, was used as a normalizer and endogenous control. The qRT-PCR-derived validation of the direction and level of expression of the 18 selected genes is displayed in Figure 3 We also performed qRT-PCR for selected genes after stimulation of RPE cells with the reverse peptide (A␤ 40-1 ) . qRT-PCR The data are presented as x-fold changes and log-transformed x-fold changes. The expression level of genes greater than 1.5-fold was considered upregulated (P Ͻ 0.05).
* Genes that are selected for verification by RT-PCR.
was performed for the 17 genes of interest obtained from the microarray analysis (Agilent) that were differentially upregulated after A␤ 1-40 stimulation. The amplified product for the same housekeeping gene, GAPDH, was used as a normalizer and endogenous control. As expected, stimulation with the control reverse peptide (A␤ 40-1 ) resulted in changes that were insignificant (Fig. 3 , gray bars) relative to those observed after A␤ 1-40 stimulation (Fig. 3 , white bars).
Supernatant Studies
Analysis of supernatants from the RPE cell culture was performed to identify the secreted levels of selected gene products. Among the three gene products (IL-8, IL-1␤, TNFSF10
[TRAIL]) examined, only IL-8 was detected in significant amounts in the supernatant samples. After stimulation with A␤ 1-40 for 24 hours, the RPE cells secreted IL-8 at an increased level compared with the untreated RPE cells. As shown in Figure 4 , the amount of secreted IL-8 was 91% higher than in the control untreated group.
Pathway Analysis
Using the mRNA expression profiles of human RPE cells treated with A␤ 1-40 , we sought to determine the functional gene sets that correlated highly with our gene expression data using two types of pathway analysis. GSEA analysis identified 50 significantly enriched gene sets that correlated with the genes induced after A␤ 1-40 treatment. Many of these gene sets are highly enriched with genes related to immune response and inflammatory processes. Table 4 lists some of the top gene sets selected by the GSEA analysis. Note that all sets include genes associated with inflammatory processes. After 24 hours, the A␤ 1-40 treatment induced strong activation of genes associated with the interferon signaling pathway, immune signaling pathways, and the NF-B signaling pathway involved in inflammatory processes (NES Ն 2.03). Leading-edge analysis of gene set 13 in Table 4 within GSEA uncovered a subset of genes, including IL-1␤ and IL-8, within this gene set that was principally responsible for the total enrichment score ( Table 5) . As IL-1␤ and -8 were both upregulated in our data set, the GSEA analysis highlights the significance of inflammatory processes in the major pathways activated after A␤ 1-40 stimulation in our study. Complementary GSEA analysis was unable to identify any pathways significantly enriched with A␤ 1-40 downregulated genes. Figure 5 lists the top genes that appear across multiple enriched gene sets from the GSEA analysis. The leading-edge analysis of our microarray data identified genes highly The data are presented as x-fold changes and log-transformed x-fold changes. Decreased expression changes are expressed as Ϫ(treatment/ control)
Ϫ1
. The expression levels of genes decreased more than Ϫ1.5-fold are considered downregulated (P Ͻ 0.05). * Genes that are selected for verification by RT-PCR. correlated with inflammation, immune response, interferonregulated genes, neurodegeneration, and apoptosis.
Pathway analysis of differentially expressed genes that reached criteria in our A␤ stimulation studies revealed the top six gene networks that reach threshold (P Ͻ 0.05) are leukocyte extravasation signaling, natural killer cell signaling, hepatic cholestasis, FXR/RXR activation, IL-10 signaling, and the complement activation (Fig. 6 ).
DISCUSSION Proinflammatory Cytokines and Chemokines
Inflammation has been strongly implicated in the pathogenesis of AMD, but the initiation of the inflammatory processes in AMD is not well understood. 4,10 -12 In this study, we hypothesized that A␤ , a component of drusen, is a candidate Table 3 . Note that the microarray data shown here and in Tables 1 and 2 25 In total, 18 genes were selected for validation by RT-PCR. Nearly, all expression patterns were comparable to the microarray data.
trigger of inflammatory processes in the retina. A␤ is known to activate the classic and alternative complement pathways in neuronal systems. 10,14,15,40 -43 The results of our study demonstrated that treatment of human RPE cells with the oligomeric form of A␤ (0.3 M) for 24 hours resulted in the upregulation of a number of inflammation-associated genes, as shown by microarray and later verified by RT PCR. The top three genes with the greatest increase after A␤ 1-40 challenge were IL-1␤, RSAD2, and IL-8. Gene set pathway analysis also concurred that the bulk of the gene responses in our study overlap with genes associated with inflammatory processes in the public databases. These results provide further support to the hypothesis that A␤ may trigger inflammatory responses in the RPE/choroidal layers of the eye.
IL-1␤ is an important proinflammatory cytokine that stimulates the activation of macrophages, and the production of cytokines such as IFN-␥, 44 -49 which promotes the upregulation of interferon ␣-inducible protein 27 (IFI27) in several types of cell lines. 50 In our studies, IFI27 was upregulated after 〈␤ 1-40 treatment and suggests that activation of pathways associated with IFN-␥ are downstream of 〈␤ 1-40 stimulation. Recently, Wu et al. 51 showed that IFN-␥, along with oxidative stress, downregulates the complement inhibitor CFH, which could lead to increased complement activation, a known risk factor in AMD. Our studies revealed that 〈␤ 1-40 stimulation of RPE cells lead to IL-1␤ upregulation. In the context of the diseased eye, it is conceivable that interactions between IL-1␤ and reactive oxygen species (ROS) in the retina induce downregulation of CFH and thus promote chronic inflammation. More studies are needed to further evaluate the downstream pathways associated with 〈␤ 1-40 stimulation.
IL-1␤
was also shown to induce ROS in RPE cells. 52 It is believed that ROS production may promote secretion of IL-8 in RPE cells. 53, 54 Thus, it is also possible that IL-1␤ can regulate the expression of IL-8 in RPE by direct and indirect (via ROS) mechanisms in RPE. 52, 53, 55, 56 Because of its chemotaxic abilities, IL-8 release may account for the observed accumulation of inflammatory cells in the regions of drusen formation in patients with AMD. The recruitment of macrophages and neutrophils and other proinflammatory cells that produce and release proteinases and angiogenic factors into drusen could also pro-FIGURE 5. GSEA leading edge gene sets analysis. The analysis selects the genes that appear across multiple enriched gene sets from the public databases. These genes are expected to have higher biological significance. The leading edge analysis of our microarray data identified gene highly correlated with inflammation, immune response, interferon-regulated genes, apoptosis, and neurodegeneration. A detailed look into this gene set shows that IL-1b and IL-8 are the top-ranked genes in our experimental A␤ dataset. Genes that are found in the leading edge of this gene set are marked "Yes"in the core enrichment column. They are the genes that significantly contribute to the total enrichment score of the NTHIPATHWAY gene set. mote neovascular events associated with the wet form of AMD. [57] [58] [59] Although, the mRNA of both IL-1␤ and -8 were significantly expressed, ELISA only detected IL-8 protein in the supernatant, perhaps because the IL-1␤ precursor protein has been shown to possess a short half-life.
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RSAD2, or viperin, was upregulated 2.58-fold in our studies. RSAD2 is a virus inducible antiviral protein associated with the innate immune response. 61 It is upregulated in atherosclerotic plaques and inducible in endothelial cells by stimulation with LPS, IFN-␥, or cytomegalovirus. This is the first report that RPE cells can differentially express RSAD2. Its specific role in AMD pathogenesis is not yet known.
CFI and CFH
In this study, we also observed increased gene expression of complement factor I (CFI), which is a known inhibitor of the complement system. CFI inhibits complement activation by inactivating complement component 3b (C3b); dysregulation of CFI promotes uncontrolled complement activation. 18, 62, 63 Recently, Fagerness et al. 64 identified a variant in the CFI gene that is associated with an increased risk of developing AMD. Wang et al. 18 discovered that A␤ stimulation of RPE cells resulted in the inability of CFI to cleave active C3b into its inactive form (iC3b). Although the mechanism remains unknown, A␤ is thought to bind to CFI and consequently inhibits its regulatory function and causes unregulated complement activation. 18 Future studies are needed to determine the interactions between A␤ and CFI that cause its dysregulation of the complement pathways and the subsequent effects on RPE function. In addition to CFI, there is evidence in the literature supporting involvement of CFH, another inhibitor of the complement cascade, based its known polymorphism in AMD. [65] [66] [67] [68] However, there was no evidence in our study or in Wang et al. 18 of 〈␤ 1-40 -induced changes in the expression of CFH in human RPE cells. This finding may relate to the interactions discussed by Wu et al. 51 in which IFN-␥, along with oxidative stress, downregulated the complement inhibitor CFH.
Angiogenic Factors
A␤ 1-40 -treated RPE cells were also observed to express several angiogenesis-related genes. We observed an increased gene expression of somatostatin receptor 2 (SSTR2) and fibronectin (FN) in RPE cells after treatment with 〈␤. Somatostatin is a neuropeptide with antiproliferative effects in a variety of normal and cancerous cells. 69 -73 Along with its receptor SSTR2, somatostatin has been identified in the RPE cells and has been demonstrated to inhibit VEGF mRNA expression, 74 a finding that is consistent with our results. On the other hand, Yoshida et al. 17 showed that stimulation of human RPE cells with 〈␤ 1-40 resulted in the altered expression of angiogenic genes, specifically vascular endothelial growth factor (VEGF). Although we did not observe changes in the levels of VEGF expression in our study, possibly due to the inhibitory effects of somatostatin on VEGF mRNA expression, the differences may also be due to the specific time courses and doses of 〈␤ 1-40 used in each study.
Another upregulated gene, FN, which codes for an extracellular matrix (ECM) glycoprotein, may also play a role in angiogenesis. It is possible that altered levels of ECM genes, including FN, can lead to abnormal RPE-choriocapillaris behavior. 8 
Apoptotic Mechanisms
The effect of the oligomeric form of 〈␤ 1-40 on RPE cell viability was assessed by MTT. Several apoptotic genes were upregulated in the microarray study and support the reduction in cell viability observed in the MTT study. qRT-PCR studies showed increased gene expression of two important caspase-independent apoptotic genes, tumor necrosis factor related apoptosisinducing ligand (TNFSF10 or TRAIL) and X-linked inhibitor of apoptosis associated factor 1 (XAF1). TRAIL, a member of the TNF superfamily, is expressed in several cell types and is activated by 〈␤ stimulation in neurons. It is believed that TRAIL expression promotes apoptotic cell death, as neutralization of TRAIL protects against 〈␤ toxicity in a human neuronal cell line. 75 XAF1, another gene upregulated in our stimulation studies, interacts with XIAP to block its anticaspase activity. 75 In earlier studies XAF1 was identified in several screens as a key mediator of apoptosis and was recently shown to dramatically sensitize cancer cells to apoptotic triggers such as TN-FSF10. 76, 77 Accordingly, it has been shown that interferoninduced apoptosis is mediated by the overexpression of XAF1, which is believed to increase susceptibility to TRAIL-induced cytotoxicity. 77 Thus, in our studies, A␤ 1-40 stimulation of RPE cells may have activated cell death in the RPE via XAF1 and TNFSF10 activity, as both genes were significantly upregulated in our study and have been shown to increase apoptosis in cancer cells. 78 Our results also showed an increased expression of CYP2D6, a member of the cytochrome P450 family that is involved in the first line of defense against oxidative stress and has been shown to detoxify reactive oxygen species (ROS).
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A␤ 1-40 stimulation of RPE cells in our study may also initiate ROS-induced signaling pathways, including stress-activated protein kinases and nuclear transcription factor NF-B.
52,80 -82
NF-B is upregulated by IL-8 and has been implicated in retinal neovascularization.
47,83
Proposed Interaction of Gene Products Differentially Expressed in RPE after A␤ 1-40 Stimulation
In conclusion, our in vitro studies lend support to the hypothesis that 〈␤ 1-40 promotes local inflammation near drusen sites and within the surrounding RPE layer that may promote the pathogenesis of AMD. 3, 10, 17 Our finding that RPE cells upregulate several genes associated with proinflammatory cytokines (IL-1␤, IL-8), interferon-inducible proteins (IFI27, IFI44L), an inhibitor of the complement cascade (CFI), and an inhibitor of oxidative stress (CYP2D6) in response to A␤ challenge, may present a novel mechanism and partial explanation for the onset of inflammation in the eye near drusen sites. A summary schematic that illustrates the proposed circuitry by which 〈␤ 1-40 may affect RPE gene expression leading to inflammatory events in the eye is shown in Figure 7 . We hypothesize that 〈␤ , known already to be present in drusen of AMD eyes, may induce RPE cells to secrete proinflammatory cytokines in which IL-1␤ may subsequently further promote overexpression of IL-8 via several known mechanisms, including ROS production. 53, 54 IL-8, an important chemokine, may promote migration and activation of immune cells (neutrophils, macrophages) toward the RPE. 82, 85, 86 The accumulation of neutrophils, macrophages, and microglial cells may cause further pathologic changes in the RPE and Bruch's membrane complex. 4, 8, 9, 81, 87 Our results also suggest that, 〈␤ 1-40 may promote RPE cells to overexpress CFI. Other in vitro studies showed that the interactions between A␤ 1-40 and CFI cause CFI to lose its complement regulatory function. 18, 62 In the absence of CFI, unregulated complement activation would take place resulting in increased inflammation. 18 Furthermore, A␤ 1-40 may also cause RPE cells to secrete IFN-␥. According to Wu et al. 51 IFN-␥ (along with oxidative stress) may reduce CFH activity, thus increasing complement activation that may further promote AMD disease progression. IL-1␤ is known to also promote generation of ROS, which may further promote IL-8 expression (dashed line). In the context of the eye, IL-8 overexpression by RPE may promote macrophage and microglial migration toward RPE and in drusen containing A␤. A prolonged macrophage and microglial response in the RPE/choroid layers may further support oxidative injury and inflammatory events through respiratory burst mechanisms. Genes for interferon-induced proteins (IFI44L and IFI27) were also upregulated in response to A␤ 1-40 stimulation in our studies. Interferon-␥, in the setting of oxidative stress, was shown to reduce CFH activity, and thus promote inflammation (dashed line). In our study, two of the genes upregulated in response to A␤ stimulation, CFI and CYP2D6, have protective value. The protective value of CYP2D6 is in its ability to act as a first line of defense against oxidative stress by detoxifying reactive oxygen species (ROS). 12 CFI, an inhibitor of the complement cascade, may work to inhibit the complement cascade; however, A␤ was shown to deleteriously interact with CFI causing its regulatory functions to be abolished. 18, 62 In the absence of CFI, unregulated complement activation would take place resulting in increased inflammation. 84 Studies that support the pathways shown: 1, Poleganov et al. 49 ; 2, Yang et al. 52 ; 3, Elner et al. 53 and Bian et al. 54 ; 4, Wu et al. 51 ; 5, Chen et al. 68 ; and 6, Wang et al. 18 
